197 related articles for article (PubMed ID: 23886458)
1. [Intracranial hemorrhages: epidemiology and implication of antithrombotic therapy].
Varvat J; Epinat M; Nuti C; Antoine JC; Mismetti P; Garnier P
Therapie; 2013; 68(3):143-7. PubMed ID: 23886458
[TBL] [Abstract][Full Text] [Related]
2. Short-term prognosis of intracranial haemorrhage in patients on oral anticoagulant or antiplatelet drugs.
Pomero F; Melchio R; Sironi A; Giraudo AV; Dentali F; Fenoglio LM; Squizzato A
Thromb Res; 2013; 132(6):765-9. PubMed ID: 24157084
[TBL] [Abstract][Full Text] [Related]
3. Antithrombotic therapy and predilection for cerebellar hemorrhage.
Toyoda K; Okada Y; Ibayashi S; Inoue T; Yasumori K; Fukui D; Uwatoko T; Makihara N; Minematsu K
Cerebrovasc Dis; 2007; 23(2-3):109-16. PubMed ID: 17124390
[TBL] [Abstract][Full Text] [Related]
4. [Intracranial hemorrhage in adults: place of antithrombotic treatment].
Carlucci L; De Pomerol M; Laguerre D; Gimbert E; Dautheribes M; San-Galli F; Liguoro D; Le-Gall M; Vignes JR
Neurochirurgie; 2013 Feb; 59(1):17-22. PubMed ID: 23414772
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcome after anticoagulation-associated intracerebral haemorrhage with or without restarting antithrombotic therapy.
Gathier CS; Algra A; Rinkel GJ; van der Worp HB
Cerebrovasc Dis; 2013; 36(1):33-7. PubMed ID: 23920426
[TBL] [Abstract][Full Text] [Related]
6. Vitamin K antagonist-associated intracerebral hemorrhage: lessons from a devastating disease in the dawn of the new oral anticoagulants.
Suárez-Pinilla M; Fernández-Rodríguez Á; Benavente-Fernández L; Calleja-Puerta S
J Stroke Cerebrovasc Dis; 2014 Apr; 23(4):732-42. PubMed ID: 23954605
[TBL] [Abstract][Full Text] [Related]
7. Recurrence of ICH after resumption of anticoagulation with VK antagonists: CHIRONE study.
Poli D; Antonucci E; Dentali F; Erba N; Testa S; Tiraferri E; Palareti G;
Neurology; 2014 Mar; 82(12):1020-6. PubMed ID: 24562060
[TBL] [Abstract][Full Text] [Related]
8. [Morbi-mortality of medical and surgical treatments in the intracranial bleeding like complication of therapy with drugs that modifies normal coagulation].
Virgós-Señor B; Nebra-Puertas AC; López-Nuñez C; Comuñas-González F; Díaz-Vicente FJ; Luque-Gómez P; Navarro-Hernando MA; Santos-Lasaosa S; Tejero-Juste C
Rev Neurol; 2001 May 1-15; 32(9):829-32. PubMed ID: 11424033
[TBL] [Abstract][Full Text] [Related]
9. Antithrombotic Medication Use and Misuse Among Patients with Intracranial Hemorrhage: A 16-Year, Lebanese, Single-Center Experience.
Fahed E; Ghauche J; Rahme R; Okais N; Samaha E; Nohra G; Rizk T; Maarrawi J; Menassa-Moussa L; Moussa R
World Neurosurg; 2016 Nov; 95():143-147. PubMed ID: 27521729
[TBL] [Abstract][Full Text] [Related]
10. Antiplatelet Therapy in Primary Spontaneous and Oral Anticoagulation-Associated Intracerebral Hemorrhage.
Sprügel MI; Kuramatsu JB; Gerner ST; Sembill JA; Beuscher VD; Hagen M; Roeder SS; Lücking H; Struffert T; Dörfler A; Schwab S; Huttner HB
Stroke; 2018 Nov; 49(11):2621-2629. PubMed ID: 30355188
[TBL] [Abstract][Full Text] [Related]
11. Contra: "Anti-platelet therapy is an alternative to oral anticoagulation for atrial fibrillation".
Apostolakis S; Shantsila E; Lip GY; Lane DA
Thromb Haemost; 2009 Nov; 102(5):914-5. PubMed ID: 19888529
[No Abstract] [Full Text] [Related]
12. Intracranial bleeding: epidemiology and relationships with antithrombotic treatment in 241 cerebral hemorrhages in Reggio Emilia.
Nicolini A; Ghirarduzzi A; Iorio A; Silingardi M; Malferrari G; Baldi G
Haematologica; 2002 Sep; 87(9):948-56. PubMed ID: 12217807
[TBL] [Abstract][Full Text] [Related]
13. Subretinal hemorrhages associated with age-related macular degeneration in patients receiving anticoagulation or antiplatelet therapy.
Kuhli-Hattenbach C; Fischer IB; Schalnus R; Hattenbach LO
Am J Ophthalmol; 2010 Feb; 149(2):316-321.e1. PubMed ID: 19939348
[TBL] [Abstract][Full Text] [Related]
14. Antithrombotic Treatment and Clinical Outcomes After Intracerebral Hemorrhage: A Retrospective Cohort Study from the Swedish Stroke Register.
Tallroth M; Udumyan R; Büki A; von Euler M
J Am Heart Assoc; 2024 May; 13(10):e034716. PubMed ID: 38726922
[TBL] [Abstract][Full Text] [Related]
15. Delayed intracranial hemorrhage after blunt trauma: are patients on preinjury anticoagulants and prescription antiplatelet agents at risk?
Peck KA; Sise CB; Shackford SR; Sise MJ; Calvo RY; Sack DI; Walker SB; Schechter MS
J Trauma; 2011 Dec; 71(6):1600-4. PubMed ID: 22182870
[TBL] [Abstract][Full Text] [Related]
16. The Dilemma of Resuming Antithrombotic Therapy After Intracranial Hemorrhage in Patients With Left Ventricular Assist Devices.
Santos CD; Matos NL; Asleh R; Dawit S; Rabinstein AA; O'Carroll CB; Li Z; Freeman WD
Neurocrit Care; 2020 Jun; 32(3):822-827. PubMed ID: 31531758
[TBL] [Abstract][Full Text] [Related]
17. Clinical and radiological course of intracerebral haemorrhage associated with the new non-vitamin K anticoagulants.
von der Brelie C; Doukas A; Naumann R; Dempfle A; Larsen N; Synowitz M; Jansen O; Mehdorn M; Jadik S
Acta Neurochir (Wien); 2017 Jan; 159(1):101-109. PubMed ID: 27873051
[TBL] [Abstract][Full Text] [Related]
18. Impact of antithrombotic therapy on acute and delayed intracranial haemorrhage and evaluation of the need of short-term hospitalisation based on CT findings after mild traumatic brain injury: experience from an oral and maxillofacial surgery unit.
Sakkas A; Weiß C; Wilde F; Ebeling M; Thiele OC; Mischkowski RA; Pietzka S
Eur J Trauma Emerg Surg; 2024 Feb; 50(1):157-172. PubMed ID: 36707437
[TBL] [Abstract][Full Text] [Related]
19. Association of Antithrombotic Drug Use With Subdural Hematoma Risk.
Gaist D; García Rodríguez LA; Hellfritzsch M; Poulsen FR; Halle B; Hallas J; Pottegård A
JAMA; 2017 Feb; 317(8):836-846. PubMed ID: 28245322
[TBL] [Abstract][Full Text] [Related]
20. Determinants of intracranial hemorrhage incidence in patients on oral anticoagulation followed at the Lahey clinic.
Mantha S; Pianka AM; Tsapatsaris N
J Thromb Thrombolysis; 2011 Oct; 32(3):334-42. PubMed ID: 21674132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
